Sialidases in biological systems

Pharmazie

Volumn 65, Issue 8, 2010, Pages 551-561

  Schwerdtfeger, S M ^a   Melzig, M F ^a   Melzig, Matthias M ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; OSELTAMIVIR; PERAMIVIR; SIALIDASE; SIALIDASE INHIBITOR; VIRULENCE FACTOR; ZANAMIVIR; SIALIC ACID DERIVATIVE;

ACANTHAMOEBA; ANTIVIRAL ACTIVITY; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BINDING AFFINITY; DRUG RESISTANCE; EIMERIA; ENZYME INHIBITOR INTERACTION; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; FUNGUS; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; MUMPS VIRUS; NONHUMAN; NUTRITION; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS 4; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION; STREPTOCOCCUS; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA; VIBRIO CHOLERAE; VIRUS INHIBITION; VIRUS MUTATION; VIRUS VIRULENCE; ANIMAL; BACTERIA; BACTERIAL INFECTION; ENZYMOLOGY; INVERTEBRATE; MAMMAL; METABOLISM; MICROBIOLOGY; ORTHOMYXOVIRUS; PHYSIOLOGY; VIRUS;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; INVERTEBRATES; MAMMALS; NEURAMINIDASE; ORTHOMYXOVIRIDAE; SIALIC ACIDS; VIRUSES;

EID: 77955909881     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0546     Document Type: Review

References (66)

1. Achyuthan K, Achyuthan A (2001) Comparative enzymology, biochemistry and pathophysiology of human exo-α-sialidases (neuraminidases). Comp Biochem Physiol B Biochem Mol Biol 129: 29-64.
2. Amino R, Porto R, Chammas R, Egami M, Schenkman S (1998) Identification and characterization of a sialidase released by the salivary gland of the hematophagous insect Triatoma infestans. J Biol Chem 273: 24575-24582.
3. Avellón A, Cabrerizo M, de Miguel T, Pérez-Breña P, Tenorio A, Pérez JL, Victoria M, de Aragón M, Trallero G (2008) Widespread Oseltamivir resistance in Influenza A viruses (H1N1), South Africa. Emerg Infect Dis 14: 1809-1810.
4. th ed., München.
5. Boltz D, Ilyushina N, Arnold C, Babu Y, Webster R, Govorkova E (2008) Intramuscularly administered neuraminidase inhibitor peramivir is effective against H5N1 influenza virus in mice. Antiviral Res 80: 150-157.
6. Briones M, Egima C, Acosta A, Schenkman S (1994) Trans-sialidase and sialic acid acceptors from insect to mammalian stages of Trypanosoma cruzi. Exp Parasitol 79: 211-214.
7. Buchini S, Buschiazzo A, Withers S (2008) A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors. Angew Chem Int Ed Engl 47: 2700-2703.
8. Bundschuh G, Ambrosius H (1976) In: Immunologie, Stuttgart.
9. Cazzulo J, Frasch A (1992) Sapa/trans-sialidase and cruzipain: two antigens from Trypanosoma cruzi contain immunodominant but enzymatically inactive domains. FASEB J 6: 3259-3264.
10. Chavas L, Tringali C, Fusi P, et al. (2005) Crystal structure of the human cytosolic sialidase neu2. J Biol Chem 280: 469-475.
11. Chen B, Leser G, Morita E, Lamb R (2007) Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol 81: 7111-7123.
12. Chou M, Li S, Li Y (1996) Cloning and expression of sialidase 1, aNeuAcα2-3galspecific sialidase from the leech, Macrobdella decora. J Biol Chem 271: 19219-19224.
13. Chuang N, Yang B (1990)Asialidase from the hepatopancreas of the shrimp Penaeus japonicus (crustacea: Decapoda): reversible binding with the acidic betagalactosidase. Comp Biochem Physiol C 97: 353-356.
14. Colli W (1993) Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J 7: 1257-1264.
15. Corfield T (1992) Bacterial sialidases-roles in pathogenicity and nutrition. Glycobiology 2: 509-521.
16. th ed.
17. Ferraris O, Lina B (2008) Mutation of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol 41: 13-19.
18. Fick J, Lindberg R, Tysklind M, Haemig P, Waldenström J, Wallensten A, Olsen B (2007) Antiviral oseltamivir is not removedor degraded in normal sewage water treatment: Implications for development of resistance by influenza a virus. PLoS One 2: e986.
19. Fleming DM, Elliot AJ, Meijer A, Paget WJ (2009) Influenza virus resistance to oseltamivir: what are the implications? Eur J Public Health 19: 238-239.
20. nd ed.
21. Frasch A (2000) Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol Today 16: 282-286.
22. Huang IC, Li W, Sui J, Marasco W, Choe H, Farzan M (2008) Influenza a virus neuraminidase limits viral superinfection. J Virol 82: 4834-4843.
23. Hummel K (1965) On the effect of cholera neuraminidase in comparison with other neuraminic acid splitting enzymes of plant and animal origin on a few physicochemical properties of human erythrocytes. Pathol Microbiol 28: 891-900.
24. Hungnes O, Dudman S (2008) Resistens hos influensavirus. Tidsskr Nor Laegeforen 128: 2601-2606.
25. Jedrzejas M (2001) Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 65: 187-207.
26. Kellogg G, Moscona A, Porotto M, Fornabaio M (2007) A second receptor binding site on human parainfluenza virus type 3 hemagglutininneuraminidase contributes to activation of the fusion mechanism. J Virol 81: 3216-3228.
27. Kramarz P, Monnet D, Nicoll A, Yilmaz C, Ciancio B (2009) Use of oseltamivir in 12 europeane countries between 2002 and 2007 - lack of association with the apperance of Oseltamivir-resistant influenza A (H1N1) viruses. Euro Surveill 14: 1-5.
28. Leckenby A, Thompson CI, Democratis J (2008) The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 21: 626-638.
29. Lamb R, Paterson R, Jardetzky T (2006) Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures. Virology 344: 30-37.
30. Lemmon K, Rima B, McQaid S, Allen I, Duprex W (2007) The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol 81: 8293-8302.
31. th ed., Heidelberg.
32. Matrosovich M, Matrosovich T, Gray T, Roberts N, Klenk HD (2004) Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78: 12665-12667.
33. McKimm-Breschin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F, Zambon M (2003) Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 47: 2264-2272.
34. Medina-Acosta E, Paul S, Tomlinson S, Pontes de Carvalho L (1994) Combined occurrence of trypanosomal sialidase/trans-sialidase activities and leihmanial metalloproteinase gene homologues in Endotrypanum sp. Mol Biochem Parasitol 64: 273-282.
35. Miyagi T, Wada T, Yamaguchi K, Hata K, Shiozaki K (2008) Plasma membraneassociated sialidase as a crucial regulator of transmembrane signalling. J Biochem 144: 279-285.
36. nd ed., Heidelberg.
37. Monti E, Preti A, Venerando B, Borsani G (2002) Recent development in mammalian sialidase molecular biology. Neurochem Res 27: 649-663.
38. Monti E, Bassi M, Bresciani R, et al. (2004) Molecular cloning and characterization of neu4, the fourth member of the human sialidase gene family. Genomics 83: 445-453.
39. Moscona A (2005) Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest 115: 1688-1698.
40. Nakano V, Piazza R, Avila-Campos M (2006) A rapid assay of the sialidase activity in species of the bacteroides fragilis group by using peanut lectin hemagglutination. Anaerobe 12: 238-241.
41. Neres J, Bryce R, Douglas K (2008) Rational drug design in parasitology: transsialidase as a case study for chagas disease. Drug Discov Today 13: 110-117.
42. Nicoll A, Ciancio B, Kramarz P, Influenza Project Team (2008) Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications. Euro Surveill 13: pii=8025.
43. Ohuchi M, Asaoka N, Sakai T, Ohuchi R (2006) Roles of neuraminidase in the initial stage of influenza virus infection. Microbes Infect 8: 1287-1293.
44. Pastoriza Gallego M, Hulen C (2006) Influence of sialic acid and bacterial sialidase on differential adhesion of Pseudomonas aeruginosa to epithelial cells. Colloids Surf B Biointerfaces 52: 154-156.
45. Pellegrin J, Ortega-Barria E, Barza M, Baum J, Pereira M (1991) Neuraminidase activity in Acanthamoeba species trophozoites and cysts. Invest Ophthalmol Vis Sci 32: 3061-3066.
46. Pellegrin J, Ortega-Barria E, Prioli R, Buerger M, Strout R, Alroy J, Pereira M(1993) Identification of a developmentally regulated sialidase in Eimeria tenella that is immunologically related to the Trypanosoma cruzi enzyme. Glycoconj J 10: 57-63.
47. st ed., Stuttgart.
48. Reece PA (2007) Neuraminidase Inhibitor Resistance in Influenza Viruses. J Med Virol 79: 1577-1586.
49. Rinninger A, Richet C, Pons A, Kohla G, Schauer R, Bauer HC, Zanetta JP, Vlasak R (2006) Localisation and distribution of O-acetylated N-acetylneuraminic acids, the endogenous substrates of the hemagglutinin-esterases of murine coronavirus, in mouse tissue. Glycoconj J 23: 73-84.
50. Roggentin P, Schauer R, Hoyer L, Vimr E (1993) The sialidase superfamily and its spread by horizontal gene transfer. Mol Microbiol 9: 915-921.
51. Russell R, Haire L, Stevens D, et al. (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443: 45-49.
52. Schauer R (2000) Achievements and challenges of sialic acid research. Glycoconj J 17: 485-499.
53. Schenkman S, Eichinger D, Pereira M, Nussenzweig V (1994) Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol 48: 499-523.
54. Schwerdtfeger SM (2007) Untersuchungen zum Einfluss von Pflanzenextrakten und Naturstoffen auf die Aktivität der Neuraminidase. Diplomarbeit, Institut für Biologie, Freie Universität Berlin.
55. Schwerdtfeger SM, Melzig MF (2008) Wirkung von Pflanzenextrakten auf die Neuraminidaseaktivität. Z Phytother 29: 65-70.
56. Singer A, Nunn M, Gould E, Johnson A (2007) Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect 115: 102-106.
57. Soong G, Muir A, Gomez M, Waks J, Reddy B, Planet P, Singh P, Kanetko Y, Wolfgang M, Hsiao Y, Tong L, Prince A (2006) Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest 116: 2297-2305.
58. Takimoto T, Portner A (2004) Molecular mechanism of paramyxovirus budding. Virus Res 106: 133-145.
59. Taylor G (1996) Sialidases: structures, biological significance and therapeutic potential. Curr Opin Struct Biol 6: 830-837.
60. Traving C, Schauer R (1998) Stucture, function and metabolism of sialic acids. Cell Mol Life Sci 54: 1330-1349.
61. von Itzstein M, Wu WY, Kok G, et al. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363: 418-423.
62. Wiggins R, Hicks S, Soothill P, Millar M, Corfield A (2001) Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract. Sex Transm Inf 77: 402-408.
63. Yamaguchi K, Hata K, Koseki K, Shiozaki A, Wada T, Moriya S, Miyagi T (2005) Evidence for mitochondrial localization ofanovel human sialidase (Neu4). Biochem J 390: 85-93.
64. Yen H, Hoffmann E, Taylor G, Scholtissek C, Monto A, Webster R, Govorkova E (2006) Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistence of influenza viruses. J Virol 80: 8787-8795.
65. Yuan P, Leser G, Demeler B, Lamb R, Jardetzky T (2008) Domain architecture and oligomerization properties of paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. Virology 378: 282-291.
66. Zeleny R, Kolarich D, Strasser R, Altmann F (2006) Sialic acid concentrations in plants are in the range of inadvertent contamination. Planta 224: 222-227.